分类 | N | 疗效 | 有效率(%) | 统计量 | P | |||
CR | PR | SD | PD | |||||
年龄 |
|
|
|
|
|
|
|
|
≤40 | 29 | 1 | 13 | 15 | 0 | 48.28 | 6.706 | 0.082 |
41~50 | 60 | 2 | 41 | 17 | 0 | 70.00 |
|
|
51~60 | 38 | 7 | 19 | 12 | 0 | 68.42 |
|
|
>61 | 4 | 0 | 4 | 0 | 0 | 100 |
|
|
FIGO分期 |
|
|
|
|
|
|
|
|
IB2 | 88 | 8 | 50 | 30 | 0 | 65.91 | 0.163 | 0.870 |
IIA2 | 43 | 2 | 27 | 14 | 0 | 67.44 |
|
|
病理类型 |
|
|
|
|
|
|
|
|
鳞癌 | 110 | 9 | 73 | 28 | 0 | 74.55 | 19.490 | <0.001 |
腺癌 | 19 | 1 | 4 | 14 | 0 | 33.33 |
|
|
腺鳞癌 | 2 | 0 | 0 | 2 | 0 | 0 |
|
|
分化程度 |
|
|
|
|
|
|
|
|
GI | 12 | 1 | 5 | 6 | 0 | 50.00 | 8.049 | 0.018 |
G2 | 80 | 2 | 48 | 30 | 0 | 62.50 |
|
|
G3 | 39 | 7 | 24 | 8 | 0 | 79.49 |
|
|
肿块直径 |
|
|
|
|
|
|
|
|
≤5 cm | 112 | 9 | 63 | 40 | 0 | 64.29 | 0.934 | 0.350 |
>5 cm | 19 | 1 | 14 | 4 | 0 | 78.95 |
|
|
给药途径 |
|
|
|
|
|
|
|
|
动脉介入 | 81 | 5 | 53 | 23 | 0 | 71.60 | 1.104 | 0.269 |
静脉滴注 | 50 | 5 | 24 | 21 | 0 | 58.00 |
|
|